Compare NVGS & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVGS | AORT |
|---|---|---|
| Founded | 1997 | 1984 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.1B |
| IPO Year | N/A | 1993 |
| Metric | NVGS | AORT |
|---|---|---|
| Price | $17.54 | $44.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $21.50 | ★ $49.36 |
| AVG Volume (30 Days) | 310.8K | ★ 346.5K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | ★ 33.99 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $578,158,000.00 | $422,646,000.00 |
| Revenue This Year | $2.77 | $15.97 |
| Revenue Next Year | $0.18 | $10.96 |
| P/E Ratio | $11.54 | ★ N/A |
| Revenue Growth | 2.46 | ★ 9.81 |
| 52 Week Low | $10.55 | $21.97 |
| 52 Week High | $18.29 | $48.04 |
| Indicator | NVGS | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 53.55 | 51.19 |
| Support Level | $17.20 | $42.68 |
| Resistance Level | $18.07 | $46.02 |
| Average True Range (ATR) | 0.35 | 1.35 |
| MACD | -0.12 | -0.18 |
| Stochastic Oscillator | 37.00 | 53.39 |
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.